A case report of pacemaker endocarditis presenting as osteitis in a high-surgical-risk patient: a management challenge with thromboaspiration and leadless pacemaker implantation Authors: Wassim Beladel, Zakaria Chaib, Caroline Birgy, Isabelle lecardonnel, Mohamed El Minaoui Published: 2026 ABSTRACT AbstractBackgroundCardiac implantable electronic device-related infective endocarditis is a serious and increasingly frequent complication, often presenting atypically in frail patients with multiple comorbidities.Case summaryWe report the case of an 83-year-old man admitted with fever and heel pain, who developed heart failure symptoms. Investigations revealed Staphylococcus aureus bacteraemia, osteitis, spondylodiscitis, and a large tricuspid valve vegetation (26 mm) attached to the pacemaker lead, complicated by pulmonary embolism. Given his high surgical risk and resistant Gram-positive bacteraemia, a multidisciplinary endocarditis team opted for percutaneous vegetation thromboaspiration and complete device extraction, and pacing was ensured via an externalized temporary-permanent pacing system. After infection clearance, a leadless pacemaker was successfully implanted. The clinical outcome was favourable, with no recurrence or complications on follow-up.ConclusionThis case emphasizes the importance of early suspicion, advanced imaging, and tailored management of cardiac implantable electronic device-related endocarditis. Leadless pacemakers and percutaneous aspiration represent valuable strategies in high-risk patients to reduce infection recurrence and embolic risk. Leadless pacemakers provide an attractive pacing option in patients at high risk of reinfection. Leadless pacemakers provide an attractive pacing option in patients at high risk of reinfection. Device-related endocarditis may have an atypical clinical presentation, requiring the use of transoesophageal and 3D echocardiography for accurate diagnosis. Device-related endocarditis may have an atypical clinical presentation, requiring the use of transoesophageal and 3D echocardiography for accurate diagnosis. Introduction The incidence of cardiac implantable electronic device-related infective endocarditis (CIED-IE) is rising steadily, driven by expanding implantation indications, an aging and frail patient population, and the increasing need for pulse generator replacements. Leadless pacemakers (LPs) offer a promising alternative, providing an effective and safe option, particularly for patients at elevated risk of infection. Management of Staphylococcus aureus bacteraemia in the context of CIED-IE remains highly challenging. Percutaneous vegetation aspiration prior to device extraction may reduce the risk of embolic complications, especially in high-surgical-risk patients. Summary figure TimelineEvents2 years earlierDual-chamber pacemaker implantationDay 1Admission to the geriatric department for fever and right heel painDay 3Blood cultures were positive for methicillin-sensitive Staphylococcus aureus, while subsequent cultures grew Staphylococcus epidermidis resistantDay 4Bone scintigraphy: right calcaneal osteitis and L1–L2 and spondylodiscitisDay 6Acute heart failure symptoms; echocardiography suggested endocarditisDay 7Transoesophageal echocardiography confirmed cardiac implantable electronic device endocarditis; transfer to the cardiology departmentDay 10Pulmonary scintigraphy revealed upper right lobar pulmonary embolismDay 13Pacemaker extraction and implantation of an externalized temporary-permanent pacing systemDay 41Clinical improvement following thromboaspiration and device extraction. After three sets of negative blood cultures, a leadless pacemaker was implantedFollow-up (1 month)No acute or late complications; stable pacing parameters Case presentation An 83-year-old male was initially admitted to the geriatric department for evaluation of fever and right heel pain. His past medical history included dual-chamber pacemaker implantation 2 years earlier for symptomatic atrioventricular dissociation, arterial hypertension, atrial flutter, Kaposi’s sarcoma, prior thyroidectomy, benign prostatic hyperplasia, moderate chronic kidney disease, and a recent hip fracture resulting in reduced autonomy. Six days after admission, he developed symptoms of acute heart failure and was transferred to the cardiology department. On admission, his vital signs were stable: temperature, 38.7°C; pulse rate, 89 bpm; respiratory rate, 25 breaths/min; oxygen saturation, 90%; and blood pressure, 112/72 mm Hg. Clinical examination revealed bilateral lower-limb oedema and fine crackles in the lower half of both lung fields. Cardiac auscultation demonstrated a regular rhythm without murmurs or additional heart sounds. The remainder of the physical examination revealed pressure ulcers localized to the heel and sacral region. Electrocardiogram demonstrated a ventricular-paced rhythm with wide QRS complexes. Laboratory investigations revealed elevated inflammatory markers with leucocytosis (22 × 109/L), markedly elevated C-reactive protein (314 mg/L), and normocytic anaemia (haemoglobin 9.3 g/dl). Blood cultures were positive for methicillin-sensitive Staphylococcus aureus (MSSA), while subsequent cultures grew Staphylococcus epidermidis resistant to all β-lactams. The heel X-ray showed no abnormalities. Bone scintigraphy demonstrated osteitis of the right calcaneus and L1–L2 spondylodiscitis. Transthoracic echocardiography (TTE) yielded suboptimal images but raised suspicion of a tricuspid valve lesion. Transoesophageal echocardiography (TOE) with three-dimensional reconstruction confirmed the presence of a large vegetation (26 mm) attached to the tricuspid valve, in close contact with the ventricular lead, which appeared thickened, without definite echocardiographic evidence of a vegetation directly involving the lead. Moderate tricuspid regurgitation was also observed (Figures 1 and 2). In view of impaired renal function, pulmonary ventilation/perfusion scintigraphy demonstrated an upper right lobar pulmonary embolism (Figure 3). Transoesophageal echocardiography demonstrating a large vegetation, visualized in both orthogonal planes. Transoesophageal echocardiography with 3D reconstruction confirmed the presence of a large vegetation (26 mm) adherent to the tricuspid valve in close association with the ventricular lead, which appeared thickened. Pulmonary ventilation/perfusion scintigraphy demonstrating an upper right lobar pulmonary embolism. Pacemaker interrogation showed dual-chamber, dual-sensed, dual-response, rate-modulated = mode at 60–130 bpm, with 90% ventricular pacing and stable pacing parameters. An initial diagnosis of right heel osteitis and L1–L2 spondylodiscitis was established, prompting the initiation of empirical antibiotic therapy with amoxicillin–clavulanic acid. Due to the absence of clinical and biological improvement, the regimen was subsequently escalated to piperacillin–tazobactam combined with clindamycin. Local wound care was also provided for heel and sacral pressure ulcers. Following the identification of MSSA and persistently elevated inflammatory markers, a cardiac evaluation was performed. Based on the 2023 ESC modified diagnostic criteria for infective endocarditis, a diagnosis of CIED-IE complicated by pulmonary embolism was confirmed. Empirical antimicrobial therapy in CIED endocarditis must initially include coverage for S. aureus. In this patient, due to the absence of clinical and biological improvement and cephalosporin resistance, treatment was escalated to vancomycin and gentamicin. After isolation of S. epidermidis resistant to all β-lactams, the antibiotic regimen was adjusted to daptomycin combined with fosfomycin. Following review by a multidisciplinary endocarditis team—including a cardiologist, an electrophysiologist, infectious disease specialists, cardiac surgeons, imaging specialists, and geriatricians—surgical intervention was deemed to carry an unacceptable operative risk, given the patient’s high surgical profile risk, persistent Gram-positive bacteraemia, and large vegetation size. A stepwise, minimally invasive strategy was pursued, encompassing percutaneous vegetation thromboaspiration, complete pacemaker system extraction, and implantation of an externalized temporary-permanent pacing system via an active-fixation lead placed through the internal jugular vein, given the patient’s 90% ventricular pacing dependency. The clinical course was uneventful following thromboaspiration and device extraction. No procedure-related complications occurred, and subsequent TTE showed no residual vegetations. Three consecutive sets of negative blood cultures and systemic infection resolved. Intravenous antibiotic therapy was continued for 4 weeks after explantation, after which a LP was successfully implanted, given the high risk of reinfection with a conventional transvenous system (Figure 4). Antibiotic therapy was maintained for an additional 2 weeks post-implantation to complete the 6-week course, after which the patient was discharged in stable condition. Chest X-ray showing the leadless pacemaker in the right ventricle. At 1-month follow-up, the patient remained free of recurrent infection, device-related complications, or heart failure symptoms. LP interrogation demonstrated stable pacing parameters. Discussion CIED-IE has emerged as a significant clinical entity due to the rising use of pacemakers and defibrillators in an aging population with multiple comorbidities.1 Right-sided IE is rare, with a prevalence of between 5% and 10%. It is often associated with intravenous drug use, intracardiac devices, and central venous catheters.2 The diagnosis can be challenging, as clinical manifestations are often non-specific and may overlap with other infections. TTE is often limited in sensitivity for CIED infections, while TOE, especially with three-dimensional reconstruction, remains the gold standard for assessing vegetation size, location, and device involvement.3 In pacemaker lead infections, the infectious process may extend to the tricuspid valve at the site of contact. Due to the anterior curvature of the lead, the anterior tricuspid leaflet appears to be more susceptible to infection than the posterior leaflet. A reduction in the incidence of septic pulmonary emboli has been reported in cases of CIED with large vegetations adherent to the intracardiac lead when percutaneous aspiration devices are employed prior to percutaneous lead extraction. It responds favourably to antibiotic therapy, and surgical intervention is required in only 5%–16% of cases.4 Management of CIED-IE requires a multidisciplinary approach involving infectious disease specialists, cardiologists, cardiac surgeons, and imaging experts to optimize patient outcomes. Standard therapy consists of a prolonged course of intravenous antibiotics, typically administered for 4–6 weeks, to ensure complete eradication of the causative pathogen.5 Initial empirical therapy should provide broad coverage against the most common pathogens, particularly S. aureus (including methicillin-resistant S. aureus) and streptococci. Vancomycin is an appropriate first-line choice, with additional agents (e.g. gentamicin or cefepime) considered based on clinical context. Once culture results and susceptibility profiles are available, therapy should be tailored accordingly. The recommended duration of intravenous antibiotic therapy is typically 4–6 weeks, counted from device removal or the first negative blood culture.6 The presence of large vegetations with persistent bacteraemia and septic embolic events, as well as severe tricuspid regurgitation leading to right-sided heart failure, constitutes the most frequent indications for surgery in IE. Prompt device removal and percutaneous lead extraction represent the cornerstone of treatment for CIED-IE, even in patients with large lead vegetations.7 The use of percutaneous vacuum-assisted devices offers a minimally invasive alternative to surgery for the removal of right-sided intracardiac masses. Its role is to remove large vegetations in patients with high surgical risk or in those who are not surgical candidates. The vacuum-assisted aspiration device carries FDA approval for the extraction of unwanted intravascular materials.8 The main goals of the extraction of large vegetations using percutaneous aspiration are to debulk septic intracardiac masses, reduce the infectious burden, and achieve clinical stability.4 Complete CIED extraction is strongly recommended in the case of valvular infective endocarditis, even in the absence of lead involvement. This represents a Class I indication and is considered standard of care. Debulking of right intra-atrial septic vegetations may be considered in patients who are at high surgical risk. Current extraction guidelines specify that percutaneous aspiration or debulking is particularly recommended for large vegetations, generally exceeding 20 mm in size, given the increased risk of septic pulmonary embolism during extraction. Reimplantation during active infection carries a high risk of relapse, and guidelines recommend postponing device reimplantation until blood cultures are persistently negative and infection is controlled.9 The most distinctive feature in our case was the use of percutaneous vegetation aspiration as part of the management strategy. Our patient presented with a vegetation measuring 26 mm attached to the tricuspid valve; the medical therapy alone was deemed insufficient, given the persistence of the vegetation, sustained systemic inflammation, and the gram-positive bacteraemia despite appropriate antimicrobial therapy, compounded by documented septic pulmonary embolism. These features confer an increased risk of further embolic events and treatment failure. Surgical management was precluded by advanced age, frailty, multiple comorbidities, chronic kidney disease, reduced functional status, and the high operative risk. Percutaneous vegetation thromboaspiration was therefore performed before device extraction and selected as a bridge to transvenous lead extraction to reduce embolic burden and optimize procedural safety. To our knowledge, such an approach remains relatively uncommon in routine practice, and its inclusion highlights a valuable therapeutic option in selected high-risk cases.